The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management†
Open accessAbstract
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease in the western world. It is now recognized that these patients have myriad of important co-morbidities (e.g., diabetes, hypothyroidism and metabolic syndrome). The workup of patients with suspected NAFLD should consist of excluding competing etiologies and systemic evaluation of metabolic comorbidities. NAFLD is histologically categorized into steatosis and steatohepatitis, two states with fairly dichotomous natural history. While significant progress has been made in terms of noninvasively predicting advanced fibrosis, insufficient progress has been made in predicting steatohepatitis. Currently, liver biopsy remains the gold standard for the histological stratification of NAFLD. While sustained weight loss can be effective to treat NASH, it is often difficult to achieve. Foregut bariatric surgery can be quite effective in improving hepatic histology in selected patients without liver failure or significant portal hypertension. Thiazolidinediones have shown promise and the results from the ongoing, large multicenter study should become available soon. Large multicenter studies of CB, receptor anatagonists are also underway but their results will not be available for several years. Several recent studies have highlighted that cardiovascular disease is the single most important cause of morbidity and mortality in this patient population. CONCLUSION: Health care providers should not only focus on liver disease but also concentrate on aggressively modifying and treating their cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Angelico, F., Burattin, M., Alessandri, C., Ben, M. D., & Lirussi, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005166.pub2 · Cited by 119
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
The prevalence and etiology of elevated aminotransferase levels in the United States
Clark, J. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00265-x · Cited by 1,360
Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Serum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., Hubscher, S., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,102
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Guha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 691
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Leers, M. P. G., K�lgen, W., Bj�rklund, V., Bergman, T., Tribbick, G., Persson, B., Bj�rklund, P., Ramaekers, F. C. S., Bj�rklund, B., Nap, M., et al. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199904)187:5<567::aid-path288>3.0.co;2-j · Cited by 642
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
McCullough, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.004 · Cited by 580
Ding, X., Saxena, N. K., Lin, S., Gupta, N., & Anania, F. A. (2006) · Hepatology · doi:10.1002/hep.21006 · Cited by 557
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505
Ratziu, V., Massard, J., Charlotte, F., Messous, D., Imbert-Bismut, F., Bonyhay, L., Tahiri, M., Munteanu, M., Thabut, D., Cadranel, J. F., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-6 · Cited by 492
Hattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000221429.94591.72 · Cited by 487
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J., Emick, D., Lok, A. S., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 444
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.015 · Cited by 441
Self-citationSanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
Zivkovic, A. M., German, J. B., & Sanyal, A. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.285 · Cited by 422
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., & Sheppard, B. L. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03553.x · Cited by 394
Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369
Diagnosis and Therapy of Nonalcoholic Steatohepatitis
Torres, D. M., & Harrison, S. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.077 · Cited by 354
Nonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Self-citationFraser, A., Longnecker, M. P., & Lawlor, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.077 · Cited by 327
Merriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 324
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
Talwalkar, J. A., Yin, M., Fidler, J. L., Sanderson, S. O., Kamath, P. S., & Ehman, R. L. (2008) · Hepatology · doi:10.1002/hep.21972 · Cited by 314
Gary-Bobo, M., Elachouri, G., Gallas, J. F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304
Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2060-x · Cited by 294
CDT, GGT, and AST As Markers of Alcohol Use: The WHO/ISBRA Collaborative Project
Conigrave, K. M., Degenhardt, L. J., Whitfield, J. B., Saunders, J. B., Helander, A., & Tabakoff, B. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200203000-00005 · Cited by 283
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
Yoneda, M., Fujita, K., Inamori, M., Nakajima, A., Tamano, M., & Hiraishi, H. (2007) · Gut · doi:10.1136/gut.2007.126417 · Cited by 278
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology
McCullough, A. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00468-7 · Cited by 271
Statins and hepatotoxicity: Focus on patients with fatty liver†
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 265
Self-citationNonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Lewis, J. H., Mortensen, M. E., Zweig, S., Fusco, M. J., Medoff, J. R., & Belder, R. (2007) · Hepatology · doi:10.1002/hep.21848 · Cited by 248
Chitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Schwimmer, J. B., Middleton, M. S., Deutsch, R., & Lavine, J. E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02420.x · Cited by 243
Targher, G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02025.x · Cited by 242
Ruhl, C. E., & Everhart, J. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00743-3 · Cited by 242
Chronic liver injury during obstructive sleep apnea†
Tanné, F., Gagnadoux, F., Chazouillères, O., Fleury, B., Wendum, D., Lasnier, E., Lebeau, B., Poupon, R., & Serfaty, L. (2005) · Hepatology · doi:10.1002/hep.20725 · Cited by 238
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
Bellentani, S., Dalle Grave, R., Suppini, A., & Marchesini, G. (2008) · Hepatology · doi:10.1002/hep.22009 · Cited by 237
Fargion, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02615-6 · Cited by 233
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Paschou, S. A., Polyzos, S. A., Anagnostis, P., Goulis, D. G., Kanaka-Gantenbein, C., Lambrinoudaki, I., Georgopoulos, N. A., & Vryonidou, A. (2020) · Endocrine · doi:10.1007/s12020-019-02085-7 · Cited by 231
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., Muggeo, M., & Day, C. P. (2008) · Obesity · doi:10.1038/oby.2008.64 · Cited by 214
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Dunn, W., Xu, R., & Schwimmer, J. B. (2008) · Hepatology · doi:10.1002/hep.22292 · Cited by 213
Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., & Brown, A. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2774 · Cited by 210
Perseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L., Maraschi, A., Catapano, A., & Fargion, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 209
Adams, L. A., Lindor, K. D., & Angulo, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30444.x · Cited by 207
Newton, J. L., Jones, D. E. J., Henderson, E., Kane, L., Wilton, K., Burt, A. D., & Day, C. P. (2008) · Gut · doi:10.1136/gut.2007.139303 · Cited by 201
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193
Musso, G., Gambino, R., Biroli, G., Carello, M., Faga, E., Pacini, G., De Michieli, F., Cassader, M., Durazzo, M., Rizzetto, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00297.x · Cited by 192
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cerda, C., Pérez-Ayuso, R. M., Riquelme, A., Soza, A., Villaseca, P., Sir-Petermann, T., Espinoza, M., Pizarro, M., Solis, N., Miquel, J. F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.012 · Cited by 187
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 180
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01817.x · Cited by 173
Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Gambarin–Gelwan, M., Kinkhabwala, S. V., Schiano, T. D., Bodian, C., Yeh, H., & Futterweit, W. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.010 · Cited by 169
Yilmaz, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i6.837 · Cited by 168
Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis?
Liangpunsakul, S., & Chalasani, N. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200310000-00014 · Cited by 167
Self-citationNonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children
Pacifico, L., Cantisani, V., Ricci, P., Osborn, J. F., Schiavo, E., Anania, C., Ferrara, E., Dvisic, G., & Chiesa, C. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318165b8e7 · Cited by 166
Wong, G. L., Wong, V. W., Choi, P. C., Chan, A. W., Chum, R. H., Chan, H. K., Lau, K. K., Chim, A. M., Yiu, K. K., Chan, F. K., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.038 · Cited by 160
Laparoscopic Sleeve Gastrectomy: Surgical Technique, Indications and Clinical Results
Braghetto, I., Owen Korn, B., Héctor Valladares, H., Gutiérrez, L., Csendes, A., Anibal Debandi, L., Castillo, J., Rodríguez, A. G., Burgos, A. M., & Brunet, L. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9421-2 · Cited by 154
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
Scheen, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00002 · Cited by 151
Health‐related fitness and physical activity in patients with nonalcoholic fatty liver disease†‡
Krasnoff, J. B., Painter, P. L., Wallace, J. P., Bass, N. M., & Merriman, R. B. (2008) · Hepatology · doi:10.1002/hep.22137 · Cited by 148
Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates
Loria, P., Lonardo, A., Leonardi, F., Fontana, C., Carulli, L., Verrone, A. M., Borsatti, A., Bertolotti, M., Cassani, F., Bagni, A., et al. (2003) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000004522.36120.08 · Cited by 142
Utility of a New Model to Diagnose an Alcohol Basis for Steatohepatitis
Dunn, W., Angulo, P., Sanderson, S. O., Jamil, L. H., Stadheim, L. M., Rosen, C. B. B., Malinchoc, M., Kamath, P. S., & Shah, V. H. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.020 · Cited by 142
Pathology of nonalcoholic steatohepatitis
Brunt, E. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.006 · Cited by 138
Results of Laparoscopic Gastric Bypass in Patients with Cirrhosis
Dallal, R. M., Mattar, S. G., Lord, J. L., Watson, A. R., Cottam, D. R., Eid, G. M., Hamad, G. G., Rabinovitz, M., & Schauer, P. R. (2004) · Obesity Surgery · doi:10.1381/096089204772787284 · Cited by 134
Vuppalanchi, R., Chalasani, N., & Teal, E. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200502000-00002 · Cited by 133
Self-citationCharlton, M., Angulo, P., Chalasani, N., Merriman, R., Viker, K., Charatcharoenwitthaya, P., Sanderson, S. O., Gawrieh, S., Krishnan, A., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22063 · Cited by 125
Self-citationNobili, V., Manco, M., Ciampalini, P., Alisi, A., Vito, R. D., Bugianesi, E., MARCELLINI, M., & Marchesini, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.06.012 · Cited by 125
Prevalence and Significance of Autoantibodies in Patients With Non-Alcoholic Steatohepatitis
Cotler, S. J., Kanji, K., Keshavarzian, A., Jensen, D. M., & Jakate, S. M. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139072.38580.a0 · Cited by 122
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60008-2 · Cited by 119
Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep Apnea
Kheirandish-Gozal, L., Sans Capdevila, O., Kheirandish, E., & Gozal, D. (2008) · Chest · doi:10.1378/chest.07-0773 · Cited by 118
Akabame, S., Hamaguchi, M., Tomiyasu, K.-I., Tanaka, M., Kobayashi-Takenaka, Y., Nakano, K., Oda, Y., & Yoshikawa, T. (2007) · Circulation Journal · doi:10.1253/circj.72.618 · Cited by 117
Kaneda, H., Hashimoto, E., Yatsuji, S., Tokushige, K., & Shiratori, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04447.x · Cited by 116
Poon, T., Nelson, P., Shen, L. Z., Mihm, M. J., Taylor, K., Fineman, M. S., & Kim, D. S. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.467 · Cited by 105
Vemuri, K. V., Janero, D. R., & Makriyannis, A. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.012 · Cited by 103
Tsuda, N., Okada, M., & Murakami, T. (2007) · Investigative Radiology · doi:10.1097/01.rli.0000258058.44876.a5 · Cited by 98
The effect of thiazolidinediones on adiponectin serum level: a meta‐analysis
Riera‐Guàrdia, N., & Rothenbacher, D. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00755.x · Cited by 91
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis
Portincasa, P., Grattagliano, I., Lauterburg, B. H., Palmieri, V. O., Palasciano, G., & Stellaard, F. (2006) · Clinical Science · doi:10.1042/cs20050346 · Cited by 91
Anton, R. F., Dominick, C., Bigelow, M. R., & Westby, C. (2001) · PubMed · Cited by 86
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
Loria, P., Lonardo, A., Bellentani, S., Day, C., Marchesini, G., & Carulli, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.007 · Cited by 82
Liver Enzymes and Histology in Obese Patients With Obstructive Sleep Apnea
Kallwitz, E. R., Herdegen, J. J., Madura, J., Jakate, S. M., & Cotler, S. J. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225692.62121.55 · Cited by 79
Long-Term Consequences After Jejunoileal Bypass for Morbid Obesity
Hocking, M. P., Davis, G. L., Franzini, D. A., & Woodward, E. R. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026698602714 · Cited by 76
Yatsuji, S., Hashimoto, E., Kaneda, H., Taniai, M., Tokushige, K., & Shiratori, K. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-005-1711-z · Cited by 76
Symptoms of Obstructive Sleep Apnea in Patients with Nonalcoholic Fatty Liver Disease
Singh, H., Pollock, R., Uhanova, J., Kryger, M. H., Hawkins, K., & Minuk, G. Y. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3058-y · Cited by 75
Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations
Solga, S. F., Alkhuraishe, A. R., Cope, K. A., Tabesh, A., Clark, J. M., Torbenson, M. S., Schwartz, P., Magnuson, T. H., Diehl, A. M., & Risby, T. H. (2006) · Biomarkers · doi:10.1080/13547500500421070 · Cited by 73
The comparative effects of bariatric surgery on weight and type 2 diabetes
Lévy, P., Fried, M., Santini, F., & Finer, N. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9214-z · Cited by 70
Horoz, M., Bölükbaş, C., Bolukbas, F. F., Sabuncu, T., Aslan, M., Sarifakiogullari, S., Gunaydin, N., & Erel, Ö. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-35 · Cited by 62
Liver Transplantation After Jejunoileal Bypass for Morbid Obesity
Lowell, J. A., Surendra, S., Ghalib, R., Caldwell, C., White, F. V., Peters, M., & Howard, T. K. (1997) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)00894-8 · Cited by 56
Sears, D. M., Fillmore, G., Bui, M., & Rodriguez, J. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9604-x · Cited by 56
Shadid, S., & Jensen, M. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1053/s1542-3565(03)00198-8 · Cited by 52
Surgical Management of Morbid Obesity
Tessier, D. J., & Eagon, J. C. (2008) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2007.12.003 · Cited by 47
Insight into hepatotoxicity: The troglitazone experience†
Watkins, P. B. (2005) · Hepatology · doi:10.1002/hep.20598 · Cited by 45
Clinicopathological significance of antinuclear antibodies in non‐alcoholic steatohepatitis
Niwa, H., Sasaki, M., Haratake, J., Kasai, T., Katayanagi, K., Kurumaya, H., Masuda, S., Minato, H., Zen, Y., Uchiyama, A., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00150.x · Cited by 42
Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle
Bugianesi, E. (2007) · Hepatology · doi:10.1002/hep.22105 · Cited by 36
[Mechanisms of action of thiazolidinediones].
Girard, J. R. (2001) · PubMed · Cited by 29
Predictors of Cirrhosis in Hispanic Patients with Nonalcoholic Steatohepatitis
Alazmi, W. M., Regev, A., Molina, E. G., & Schiff, E. R. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9065-1 · Cited by 13
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Self-citationMartin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Xiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G. (2017) · Hepatology · doi:10.1002/hep.29302 · Cited by 895
Metadata
- Authors
- Vuppalanchi, R., & Chalasani, N.
- Venue
- Hepatology
- Published
- 2009-01
- Volume
- 49
- Issue
- 1
- Pages
- 306-317
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1984669204
- Cited by
- 563
- References
- 139
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.